Enhabit (EHAB) Competitors $8.02 +0.17 (+2.17%) Closing price 03:59 PM EasternExtended Trading$8.04 +0.03 (+0.31%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. NHC, PACS, TDOC, VRDN, AHCO, CDNA, GRAL, PNTG, AVAH, and CSTLShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Grail (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry. Enhabit vs. National HealthCare PACS Group Teladoc Health Viridian Therapeutics AdaptHealth CareDx Grail The Pennant Group Aveanna Healthcare Castle Biosciences National HealthCare (NYSE:NHC) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation. Do analysts rate NHC or EHAB? Enhabit has a consensus target price of $8.50, suggesting a potential upside of 5.99%. Given Enhabit's stronger consensus rating and higher possible upside, analysts clearly believe Enhabit is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Enhabit 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better valuation and earnings, NHC or EHAB? National HealthCare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.30B1.15$66.80M$6.5414.71Enhabit$1.03B0.39-$80.50M-$3.11-2.58 Does the media favor NHC or EHAB? In the previous week, Enhabit had 1 more articles in the media than National HealthCare. MarketBeat recorded 3 mentions for Enhabit and 2 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.67 beat Enhabit's score of 1.12 indicating that National HealthCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Enhabit 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is NHC or EHAB more profitable? National HealthCare has a net margin of 10.03% compared to Enhabit's net margin of -11.24%. National HealthCare's return on equity of 6.87% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Enhabit -11.24%1.67%0.80% Which has more risk and volatility, NHC or EHAB? National HealthCare has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Do institutionals and insiders believe in NHC or EHAB? 56.4% of National HealthCare shares are held by institutional investors. 15.0% of National HealthCare shares are held by insiders. Comparatively, 1.9% of Enhabit shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer NHC or EHAB? Enhabit received 2 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 17.24% of users gave Enhabit an outperform vote. CompanyUnderperformOutperformNational HealthCareOutperform Votes3100.00% Underperform VotesNo VotesEnhabitOutperform Votes517.24%Underperform Votes2482.76% SummaryNational HealthCare beats Enhabit on 12 of the 18 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitHome health care services IndustryMedical SectorNYSE ExchangeMarket Cap$404.85M$3.13B$5.55B$19.21BDividend YieldN/A0.35%5.09%4.00%P/E Ratio-3.4629.7622.7533.44Price / Sales0.391.12403.9329.13Price / Cash3.2517.2938.1817.52Price / Book0.583.526.794.55Net Income-$80.50M-$57.02M$3.22B$1.02B7 Day Performance2.95%5.76%2.26%2.15%1 Month Performance-9.38%-3.81%3.63%-2.08%1 Year Performance-19.72%23.78%16.83%5.45% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit1.5492 of 5 stars$8.02+2.2%$8.50+6.0%-22.8%$404.85M$1.03B-3.4610,900Upcoming EarningsNews CoveragePositive NewsNHCNational HealthCareN/A$90.31-2.0%N/AN/A$1.40B$1.30B11.3212,400Positive NewsPACSPACS Group3.391 of 5 stars$8.58-7.3%$34.00+296.3%-60.9%$1.31B$3.56B0.0032,433Positive NewsTDOCTeladoc Health3.7909 of 5 stars$6.52-4.5%$10.82+66.0%-45.5%$1.14B$2.57B-1.135,100Analyst ForecastAnalyst RevisionNews CoverageVRDNViridian Therapeutics1.2504 of 5 stars$13.13flat$35.70+171.9%-0.5%$1.07B$302,000.00-3.0550Upcoming EarningsPositive NewsAHCOAdaptHealth3.4935 of 5 stars$7.33-5.9%$13.80+88.3%-15.5%$988.58M$3.26B-4.4410,900Upcoming EarningsCDNACareDx3.6741 of 5 stars$16.94-3.9%$30.33+79.1%+64.2%$938.92M$333.79M-6.27740Earnings ReportInsider TradePositive NewsGap UpGRALGrail0.7922 of 5 stars$26.42-2.1%$26.00-1.6%N/A$932.55M$125.60M0.001,360PNTGThe Pennant Group3.1832 of 5 stars$24.50-6.2%$34.80+42.0%+19.6%$850.69M$695.24M36.035,340Upcoming EarningsNews CoveragePositive NewsAVAHAveanna Healthcare0.6132 of 5 stars$4.22-7.0%$5.00+18.5%+101.8%$823.30M$2.02B-12.4133,000Upcoming EarningsNews CoverageCSTLCastle Biosciences3.1094 of 5 stars$21.14-1.7%$38.75+83.3%-12.3%$609.78M$332.07M105.71540Upcoming EarningsPositive News Related Companies and Tools Related Companies NHC Competitors PACS Competitors TDOC Competitors VRDN Competitors AHCO Competitors CDNA Competitors GRAL Competitors PNTG Competitors AVAH Competitors CSTL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EHAB Stock Free EHAB Stock Alerts